Etiology of autistic features: the persisting neurotoxic effects of propionic acid

Journal of Neuroinflammation

Volumn 9, Issue , 2012, Pages

  El Ansary, Afaf K ^a   Bacha, Abir B ^a   Kotb, Malak ^b  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATALASE; CREATINE KINASE; GAMMA INTERFERON; GLUTATHIONE PEROXIDASE; HEAT SHOCK PROTEIN 70; INTERLEUKIN 6; LACTATE DEHYDROGENASE; PROPIONIC ACID; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; AUTISM; BRAIN HOMOGENATE; CONTROLLED STUDY; DNA FRAGMENTATION; DRUG EFFECT; ENERGY METABOLISM; ENZYME ACTIVATION; ENZYME ACTIVITY; LIPID PEROXIDATION; MALE; NERVOUS SYSTEM INFLAMMATION; NEUROTOXICITY; NEUROTRANSMISSION; NONHUMAN; OXIDATIVE STRESS; RAT;

EID: 84859930091     PISSN: None     EISSN: 17422094     Source Type: Journal    
DOI: 10.1186/1742-2094-9-74     Document Type: Article

References (57)

1. de Theije CG, Wu J, da Silva SL, Kamphuis PJ, Garssen J, Korte SM, Kraneveld AD. Pathways underlying the gut-to-brain connection in autism spectrum disorders as future targets for disease management. Eur J Pharmacol 2011, 668:S70.
2. Kirch DG, Wagman AM, Goldman-Rakic PS. Commentary: the acquisition and use of human brain tissue in neuropsychiatric research. Schizophr Bull 1991, 17:593.
3. Halladay AK, Amaral D, Aschner M, Bolivar VJ, Bowman A, DiCicco-Bloom E, Hyman SL, Keller F, Lein P, Pessah I, Restifo L, Threadgill DW. Animal models of autism spectrum disorders: information for neurotoxicologists. Neurotoxicology 2009, 30:811. 10.1016/j.neuro.2009.07.002, 3014989, 19596370.
4. Lawler CP, Croen LA, Grether JK, Van de WJ. Identifying environmental contributions to autism: provocative clues and false leads. Ment Retard Dev Disabil Res Rev 2004, 10:292. 10.1002/mrdd.20043, 15666339.
5. Bonnet U, Bingmann D, Wiemann M. Intracellular pH modulates spontaneous and epileptiform bioelectric activity of hippocampal CA3- neurones. Eur Neuropsychopharmacol 2000, 10:97. 10.1016/S0924-977X(99)00063-2, 10706990.
6. Karuri AR, Dobrowsky E, Tannock IF. Selective cellular acidification and toxicity of weak organic acids in an acidic microenvironment. Br J Cancer 1993, 68:1080. 10.1038/bjc.1993.485, 1968646, 8260358.
7. Cannizzaro C, Monastero R, Vacca M, Martire M. [3H]-DA release evoked by low pH medium and internal H + accumulation in rat hypothalamic synaptosomes: involvement of calcium ions. Neurochem Int 2003, 43:9. 10.1016/S0197-0186(02)00211-5, 12605878.
8. Severson CA, Wang W, Pieribone VA, Dohle CI, Richerson GB. Mid brain serotonergic receptors neurons are central pH chemoreceptors. Nat Neurosci 2003, 6:1139. 10.1038/nn1130, 14517544.
9. MacFabe DF, Cain DP, Rodriguez-Capote K, Franklin AE, Hoffman JE, Boond F, Taylor AR, Kavaliers M, Ossenkopp KP. Neurobiological effects of intraventricular propionic acid in rats: possible role of short chain fatty acids on the pathogenesis and characteristics of autism spectrum disorders. Behav Brain Res 2007, 176:149. 10.1016/j.bbr.2006.07.025, 16950524.
10. Shultz SR, MacFabe DF, Ossenkopp KP, Scratch S, Whelan J, Taylor R, Cain DP. Intracerebroventricular injection of propionic acid, an enteric bacterial metabolic end-product, impairs social behavior in the rat: implications for an animal model of autism. Neuropharmacology 2008, 54:901. 10.1016/j.neuropharm.2008.01.013, 18395759.
11. El-Ansary AK, Ben Bacha AG, Al-Ayadhi LY. Proinflammatory and proapoptotic markers in relation to mono and di-cations in plasma of autistic patients from Saudi Arabia. J Neuroinflammation 2011, 15(8):142.
12. Chauhan A, Chauhan V. Oxidative stress in autism. Pathophysiology 2006, 13:171.
13. Burlina AB, Bonafe L, Zacchello F. Clinical and biochemical approach to the neonate with a suspected inborn error of amino acid and organic acid metabolism. Semin Perinatol 1999, 23:162. 10.1016/S0146-0005(99)80048-2, 10331467.
14. Wajner M, Latini A, Wyse AT, Dutra-Filho CS. The role of oxidative damage in the neuropathology of organic acidurias: insights from animal studies. J Inherit Metab Dis 2004, 27:427.
15. Conn AR, Fell DI, Steele RD. Characterization of alpha-keto acid transport across blood-brain barrier in rats. Am J Physiol 1983, 245:253.
16. El-Ansary AK, Bacha AG, Al-Ayahdi LY. Plasma fatty acids as diagnostic markers in autistic patients from Saudi Arabia. Lipids Health Dis 2011, 21:62.
17. Wyatt I, Farnworth M, Gyte AJ, Lock EA. L-2-chloropropionic acid metabolism and disposition in male rats: relevance to cerebellar injury. Arch Toxicol 1997, 71:668. 10.1007/s002040050443, 9363839.
18. Ruiz-Larrea MB, Leal AM, Liza M, Lacort M, de Groot H. Antioxidant effects of estradiol and 2-hydroxyestradiol on iron-induced lipid peroxidation of rat liver microsome. Steroids 1994, 59:383. 10.1016/0039-128X(94)90006-X, 7940617.
19. Jagota SK, Dani HMA. New colorimetric technique for the estimation of Vitamin C using Folin phenol reagent. Anal Biochem 1982, 15:178.
20. Beutler E, Duran O, Kelly BM. Improved method for the determination of blood glutathione. J Lab Clin Med 1963, 61:882.
21. Paglia DE, Valentine WN. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 1967, 70:158.
22. Chance B. Catalases and peroxidases, part II. Special methods. Methods Biochem Anal 1954, 1:408.
23. Szasz G. Laboratory measurement of creatine kinase activity. Proceedings of the Second International Symposium on Clinical Enzymology 1975:179.
24. Henry JB. Clinical Diagnosis and Management by Laboratory Method. Sixteenth edtion. Philadelphia, PA: WB Saunders and Company 1974,
25. Folch J, Lees M, Stanley GHS. A simple method for the isolation and purification of lipids from animal tissues. J Biol Chem 1957, 226:497.
26. Zoroglu SS, Armutcu F, Ozen S, Gurel A, Sivasli E, Yetkin O, Meram I. Increased oxidative stress and altered activities of erythrocyte free radical scavenging enzymes in autism. Eur Arch Psychiatry Clin Neurosci 2004, 254:143.
27. Yorbik O, Sayal A, Akay C, Akbiyik DI, Sohmen T. Investigation of antioxidant enzymes in children with autistic disorder. Prostaglandins Leukot Essent Fatty Acids 2002, 67:341. 10.1054/plef.2002.0439, 12445495.
28. Chauhan A, Gu F, Essa MM, Wegiel J, Kaur K, Brown WT, Chauhan V. Brain region-specific deficit in mitochondrial electron transport chain complexes in children with autism. J Neurochem 2011, 117:209. 10.1111/j.1471-4159.2011.07189.x, 21250997.
29. MacFabe DF, Cain NE, Boon F, Ossenkopp KP, Cain DP. Effects of the enteric bacterial metabolic product propionic acid on object-directed behavior, social behavior, cognition, and neuroinflammation in adolescent rats: relevance to autism spectrum disorder. Behav Brain Res 2011, 217:47. 10.1016/j.bbr.2010.10.005, 20937326.
30. Al-Mosalim O, El-Ansary A, Attas O, Al-Ayadhi L. Selected enzymes related to energy metabolism in Saudi autistic children. Clin Biochem 2009, 42:949. 10.1016/j.clinbiochem.2009.04.006, 19376103.
31. Haag M. Essential fatty acids and the brain. Can J Psychiatry 2003, 48:195.
32. Young G, Conquer J. Omega-3 fatty acids and neuropsychiatric disorders. Reprod Nutr Dev 2005, 45:1. 10.1051/rnd:2005001, 15865053.
33. Assisi A, Banzi R, Buonocore C, Capasso F, Di Muzio V, Michelacci F, Renzo D, Tafuri G, Trotta F, Vitocolonna M, Garattini S. Fish oil and mental health: the role of n-3 long chain polyunsaturated fatty acids in cognitive development and neurological disorders. Int Clin Psychopharmacol 2006, 21:319. 10.1097/01.yic.0000224790.98534.11, 17012979.
34. Mitchell RW, Hatch GM. Fatty acid transport into the brain: of fatty acid fables and lipid tails. Prostaglandins Leukot Essent Fatty Acids 2005,
35. Bazan NG. Neuroprotectin D1 (NPD1): a DHA-derived mediator that protects brain and retina against cell injury-induced oxidative stress. Brain Pathol 2005, 15:159.
36. Connor J, Gillum K, Schroit AJ. Maintenance of lipid asymmetry in red blood cells and ghosts: effect of divalent cations and serum albumin on the transbilayer distribution of phosphatidylserine. Biochim Biophys Acta 1990, 1025:82. 10.1016/0005-2736(90)90193-R, 2369579.
37. Fenton WS, Hibbeln J, Knable M. Essential fatty acids, lipid membrane abnormalities, and the diagnosis and treatment of schizophrenia. Biol Psychiatry 2000, 47:8. 10.1016/S0006-3223(99)00092-X, 10650444.
38. Sumiyoshi T, Matsui M, Itoh H, Higuchi Y, Arai H, Takamiya C, Kurachi M. Essential polyunsaturated fatty acids and social cognition in schizophrenia. Psychiatry Res 2008, 157:87. 10.1016/j.psychres.2006.05.025, 17976738.
39. Pandey NR, Sultan K, Twomey E, Sparks DL. Phospholipids block nuclear factor-kappa B and tau phosphorylation and inhibit amyloid-beta secretion in human neuroblastoma cells. Neuroscience 2009, 164:1744. 10.1016/j.neuroscience.2009.09.062, 19788916.
40. El-Ansary AK, Ben Bacha AG, Al- Ayadhi LY. Impaired plasma phospholipids and relative amounts of essential polyunsaturated fatty acids in autistic patients from Saudi Arabia. Lipids Health Dis 2011, 10:63. 10.1186/1476-511X-10-63, 3107801, 21513514.
41. Brown CM, Austin DW. Autistic disorder and phospholipids: a review. Prostaglandins Leukot Essent Fatty Acids 2011, 84:25. 10.1016/j.plefa.2010.09.007, 20970971.
42. Nelson KB, Grether JK, Croen LA. Neuropeptides and neurotrophins in neonatal blood of children with autism or mental retardation. Ann Neurol 2001, 49:597. 10.1002/ana.1024, 11357950.
43. Vargas DL, Nascimbene C, Krishnan C, Zimmerman AW, Pardo CA. Neuroglial activation and neuroinflammation in the brain of patients with autism. Ann Neurol 2005, 57:67. 10.1002/ana.20315, 15546155.
44. Zimmerman A, Jyonouchi H, Comi A, Connors S, Milstien S, Varsou A, Heyes M. Cerebrospinal fluid and serum markers of inflammation in autism. Pediatr Neurol 2005, 35:195.
45. Li X, Chauhan A, Sheikh AM, Patil S, Chauhan V, Li XM, Ji L, Brown T, Malik M. Elevated immune response in the brain of autistic patients. J Neuroimmunol 2009, 207:111. 10.1016/j.jneuroim.2008.12.002, 2770268, 19157572.
46. Ashwood P, Krakowiak P, Hertz-Picciotto I, Hansen R, Pessah I, Van de Water J. Elevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcome. Brain Behav Immun 2011, 25:40. 10.1016/j.bbi.2010.08.003, 2991432, 20705131.
47. Oblak AL, Gibbs TT, Blatt GJ. Reduced GABA receptors and benzodiazepine binding sites in the posterior cingulate cortex and fusiform gyrus in autism. Brain Res 2011, 1380:218. 3020259, 20858465.
48. Narita N, Kato M, Tazoe M, Miyazaki K, Narita M, Okado N. Increased monoamine concentration in the brain and blood of fetal thalidomide- and valproic acid-exposed rat: putative animal models for autism. Pediatr Res 2002, 52:576.
49. Azmitia EC, Singh JS, Hou XP, Wegiel J. Dystrophic serotonin axons in postmortem brains from young autism patients. Anat Rec (Hoboken) 2011, 294:1653.
50. Azmitia EC, Singh JS, Whitaker-Azmitia PM. Increased serotonin axons (immunoreactive to 5-HT transporter) in postmortem brains from young autism donors. Neuropharmacology 2011, 60:1347. 10.1016/j.neuropharm.2011.02.002, 21329710.
51. Winter C, Reutiman TJ, Folsom TD, Sohr R, Wolf RJ, Juckel G, Fatemi SH. Dopamine and serotonin levels following prenatal viral infection in mouse-implications for psychiatric disorders such as schizophrenia and autism. Eur Neuropsychopharmacol 2008, 18:712. 10.1016/j.euroneuro.2008.06.001, 2714699, 18693086.
52. Garnier C, Comoy E, Barthelemy C, Leddet I, Garreau B, Muh JP, Lelord G. Dopamine-beta-hydroxylase (DBH) and homovanillic acid (HVA) in autistic children. J Autism Dev Disord 1986, 16:23. 10.1007/BF01531575, 3957856.
53. Castro BA, Jakowec M. Molecular differences in the Fischer 344 Rat, a new animal model of autism. 2009, 1.
54. Olczak M, Duszczyk M, Mierzejewski P, Wierzba-Bobrowicz T, Majewska MD. Lasting neuropathological changes in rat brain after intermittent neonatal administration of thimerosal. Folia Neuropathol 2010, 48:258.
55. Sato S, Gobbel GT, Li Y, Kondo T, Murakami K, Sato M, Hasegawa K, Copin JC, Honkaniemi J, Sharp FR, Chan PH. Blood-brain barrier disruption, HSP70 expression and apoptosis due to 3-nitropropionic acid, a mitochondrial toxin. Acta Neurochir Suppl 1997, 70:237.
56. Al-Gadani Y, El-Ansary A, Attas O, Al-Ayadhi L. Oxidative stress and antioxidant status in Saudi autistic children. Clin Biochem 2009, 42:1032. 10.1016/j.clinbiochem.2009.03.011, 19306862.
57. Ossenkopp KP, Kelly A, Foley KA, Gibson J, Fudge MA, Kavaliers M, Cain DP, MacFabe DF. Systemic treatment with the enteric bacterial fermentation product, propionic acid, produces both conditioned taste avoidance and conditioned place avoidance in rats. Behav Brain Res 2012, 227:134. 10.1016/j.bbr.2011.10.045, 22085877.